Humana Inc (HUM):企業の財務・戦略的SWOT分析

◆英語タイトル:Humana Inc (HUM) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14228
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:66
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Humana Inc (HUM) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Humana Inc (Humana) is a provider of health insurance and Medicare plans, insurance products, and health and wellness services to healthcare providers, employers, individuals, administrators, government, and the public sector. The company’s Medicare products and services include Medicare Advantage plan, prescription drug plan, Medicare supplement insurance plans, group Medicare advantage plan and Medicare plan tools. It offers products and services for individual and family including medical plans, dental plans, vision plans, life insurance and life and supplemental plans, among others. Humana sells its products in the US through direct sales representatives and telemarketing representatives, licensed independent brokers and agents and marketing arrangement with Wal-Mart Stores Inc. Humana is headquartered in Louisville, Kentucky, the US.

Humana Inc Key Recent Developments

Feb 20,2019: Humana and PatientPing announce agreement to improve care coordination for members across North Carolina
Feb 14,2019: Humana reports fourth quarter and full year results 2018
Feb 13,2019: SMC & Humana Reach Agreement
Feb 08,2019: Humana executives say Trump”s drug rebate proposal would raise premiums, restrict consumer choice
Feb 07,2019: Aledade and Humana announce agreement expanding value-based care for Humana medicare advantage members in three states

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Humana Inc – Key Facts
Humana Inc – Key Employees
Humana Inc – Key Employee Biographies
Humana Inc – Major Products and Services
Humana Inc – History
Humana Inc – Company Statement
Humana Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Humana Inc – Business Description
Business Segment: Eliminations
Performance
Business Segment: Group and Specialty
Overview
Performance
Business Segment: Healthcare Services
Overview
Performance
Business Segment: Individual Commercial
Overview
Performance
Business Segment: Other Businesses
Performance
Business Segment: Retail
Overview
Performance
Humana Inc – Corporate Strategy
Humana Inc – SWOT Analysis
SWOT Analysis – Overview
Humana Inc – Strengths
Humana Inc – Weaknesses
Humana Inc – Opportunities
Humana Inc – Threats
Humana Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Humana Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Humana Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Humana Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 20, 2019: Humana and PatientPing announce agreement to improve care coordination for members across North Carolina
Feb 14, 2019: Humana reports fourth quarter and full year results 2018
Feb 07, 2019: Aledade and Humana announce agreement expanding value-based care for Humana medicare advantage members in three states
Feb 07, 2019: ProPath signs national agreement with Humana
Feb 06, 2019: Humana reports fourth quarter 2018 financial results; provides full year 2019 financial guidance
Jan 29, 2019: Humana announces Management Team Changes
Jan 15, 2019: Humana appoints William Shrank, MD, chief medical officer
Jan 15, 2019: Tenet and Humana Sign Multi-Year Agreement
Jan 08, 2019: New year, new health coaching tools for Humana’s Go365 wellness rewards app
Dec 19, 2018: Humana announces inaugural hospital incentive program participants
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Humana Inc, Key Facts
Humana Inc, Key Employees
Humana Inc, Key Employee Biographies
Humana Inc, Major Products and Services
Humana Inc, History
Humana Inc, Other Locations
Humana Inc, Subsidiaries
Humana Inc, Key Competitors
Humana Inc, Ratios based on current share price
Humana Inc, Annual Ratios
Humana Inc, Annual Ratios (Cont...1)
Humana Inc, Interim Ratios
Humana Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Humana Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Humana Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Humana Inc, Performance Chart (2014 - 2018)
Humana Inc, Ratio Charts
Humana Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Humana Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Humana Inc (HUM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ashok Leyland Limited:企業の戦略・SWOT・財務分析
    Ashok Leyland Limited - Strategy, SWOT and Corporate Finance Report Summary Ashok Leyland Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Laboratorios Farmaceuticos Rovi SA (ROVI):製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratorios Farmaceuticos Rovi SA (Rovi) is a developer and manufacturer of prescription and hospital products. The company offers hospital products such as Iomeron and Iopamiro, Multihance, Y Prohance, Sonovue, contrast injection systems, Sodium Heparin and Siklos. Its diagnostic products …
  • Acxiom Corporation:戦略・SWOT・企業財務分析
    Acxiom Corporation - Strategy, SWOT and Corporate Finance Report Summary Acxiom Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Topy Industries Ltd:企業の戦略・SWOT・財務分析
    Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Topy Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Evgen Pharma Plc (EVG):企業の財務・戦略的SWOT分析
    Summary Evgen Pharma Plc (Evgen Pharma), formerly Evgen Pharma Ltd is a clinical-stage drug development company. It is focused on the development of sulforaphane-based compounds for the treatment of cancer and neurological disease. Its pipeline product SFX-01 targets STAT3 signalling to inhibit stem …
  • Midmark Corp-医療機器分野:企業M&A・提携分析
    Summary Midmark Corp (Midmark) is a medical device company that manufactures and markets medical, dental and veterinary healthcare equipments. The company offers medical products such as power procedures tables and chairs, power examination tables, manual examination tables, lighting products, and i …
  • Second Sight Medical Products Inc (EYES):企業の財務・戦略的SWOT分析
    Summary Second Sight Medical Products Inc (Second Sight) is a medical device company. It develops, manufactures and markets implantable visual prosthetics for blind individuals. The company offers Argus II retinal prosthesis system, a device that restores some functional vision for people suffering …
  • GSE Systems Inc (GVP):電力:M&Aディール及び事業提携情報
    Summary GSE Systems Inc (GSE) is a provider of real-time high-fidelity simulation. The company offers a wide range of simulation, training, consulting, and engineering solutions. Its simulation, engineering, and plant services assist customers in achieving performance excellence in design, training, …
  • Brokk AB:企業の戦略的SWOT分析
    Brokk AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Skyworks Solutions, Inc.:企業の戦略・SWOT・財務情報
    Skyworks Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Skyworks Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Attunity Ltd (ATTU):企業の財務・戦略的SWOT分析
    Summary Attunity Ltd (Attunity) is a technology company that provides data management software, cloud database replication solutions, and google cloud database tools. The company provides data management software solutions that enable access, sharing, management, and distribution of data. It offers …
  • Red Lion Hotels Corporation:企業の戦略・SWOT・財務情報
    Red Lion Hotels Corporation - Strategy, SWOT and Corporate Finance Report Summary Red Lion Hotels Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Confused.Com Limited
    Confused.Com Limited - Strategy, SWOT and Corporate Finance Report Summary Confused.Com Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bukwang Pharm Co Ltd (003000)-製薬・医療分野:企業M&A・提携分析
    Summary Bukwang PharmCo Ltd (BUKWANG) is a pharmaceutical company which develops pharmaceutical products and new drugs. The company’s product portfolio includes levovir, legalon, dexid, thioctacid, lonasen, ixel, Orfil, azeptin, asima among others. Its pipeline products comprise MLR-1023, JM-010, JM …
  • Odonate Therapeutics LLC-製薬・医療分野:企業M&A・提携分析
    Summary Odonate Therapeutics LLC (Odonate) is a company that develops medicines for the treatment of cancer. It develops best in class medicines that enhance and extend the lives of patients suffering from cancer. Odonate’s lead product candidate, tesetaxel, is a novel orally administered taxane use …
  • Generex Biotechnology Corp (GNBT):医療機器:M&Aディール及び事業提携情報
    Summary Generex Biotechnology Corp (Generex) carries out the research, development and commercialization of drug delivery systems and technologies. It developed a proprietary platform technology to deliver drugs into the human body through the oral cavity. The company’s proprietary liquid formulatio …
  • Continental Resources Inc (CLR):石油・ガス:M&Aディール及び事業提携情報
    Summary Continental Resources Inc (Continental Resources) is an oil and gas company involved in the distribution of fuel and related products and services. The company offerings include supply fulfillment and energy advisory services to commercial and industrial customers. It owns and operates Bakke …
  • Vestas Wind Systems AS (VWS):企業の財務・戦略的SWOT分析
    Vestas Wind Systems AS (VWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Morneau Shepell Inc.:企業の戦略・SWOT・財務分析
    Morneau Shepell Inc. - Strategy, SWOT and Corporate Finance Report Summary Morneau Shepell Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • HomeStay Care Ltd (HSC):企業の財務・戦略的SWOT分析
    HomeStay Care Ltd (HSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆